1 Min Read
May 3 (Reuters) - Miragen Therapeutics Inc
* Servier and Miragen extend collaboration for research, development and commercialization of microrna-targeting therapeutics Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.